default author photo

Minshan Chen

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

6

DOWNLOADS

486

TOTAL CITATIONS

0

Scholarly Papers (6)

1.

Development and Validation of Prognostic Nomograms for BCLC A Stage Hepatocellular Carcinoma Beyond Milan Criteria after Curative Resection

Number of pages: 30 Posted: 30 Nov 2020
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - Department of Pancreato-Biliary Surgery, Hunan Normal University - Department of General Surgery, Hunan Normal University - Department of Hepatobiliary Surgery, Jinan University - Department of Neurology and Stroke Center, Jinan University - Department of General Surgery, Southern Medical University - Department of Hepatobiliary Surgery, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Government of the People's Republic of China - Department of Interventional Ultrasound and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 157 (474,889)

Abstract:

Loading...

Hepatocellular carcinoma; Liver resection; Nomogram; BCLC A stage

2.

NGS Reveals the Phylogeny of Multi-Organ Metastatic Colon Cancer and Molecular Determinants of Metastasis

Number of pages: 38 Posted: 06 Feb 2020
Sun Yat-sen University (SYSU) - Department of Liver Surgery, Sun Yat-sen University (SYSU) - Department of Colorectal Surgery, Sun Yat-sen University (SYSU) - Department of Pathology, Sun Yat-sen University (SYSU) - Department of Liver Surgery, Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU) - Department of Liver Surgery, OrigiMed, Inc., Sun Yat-sen University (SYSU) - Department of Colorectal Surgery, Sun Yat-sen University (SYSU) - Department of Colorectal Surgery, Sun Yat-sen University (SYSU) - Department of Liver Surgery, Sun Yat-sen University (SYSU) - Department of Liver Surgery, Sun Yat-sen University (SYSU) - Department of Colorectal Surgery, Sun Yat-sen University (SYSU) - Department of Liver Surgery, Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Liver Surgery and Sun Yat-sen University (SYSU) - Department of Colorectal Surgery
Downloads 83 (783,685)

Abstract:

Loading...

next generation sequencing, phylogenetic tree, metastatic colorectal cancer, molecular markers, organotropism

3.

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and PD-1 Inhibitor as Efficacy Therapy for Infiltrative Hepatocellular Carcinoma: A Retrospective, Multicenter, Cohort Study

Number of pages: 27 Posted: 07 Feb 2023
Government of the People's Republic of China - Department of Interventional Ultrasound, Hunan University of Chinese Medicine - Department of Ultrasound Diagnosis, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Liver Surgery, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Hunan Normal University - Department of Hepatobiliary Surgery, Sun Yat-sen University (SYSU) - Center of Hepatic-Pancreatic-Biliary Surgery, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - Department of Liver Surgery
Downloads 74 (844,901)

Abstract:

Loading...

Infiltrative hepatocellular carcinoma, Hepatic arterial infusion chemotherapy, Lenvatinib, PD-1 inhibitor, Prognosis

4.

Immune Checkpoint Inhibitors, Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib or Bevacizumab in Unresectable Hepatocellular Carcinoma: A Retrospective, Multi-Center, and Propensity Score Matching Study

Number of pages: 30 Posted: 16 Jul 2024
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Guangzhou Medical University, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 65 (924,743)

Abstract:

Loading...

Hepatocellular carcinoma, lenvatinib, bevacizumab, combination therapy, conversion resection

5.

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy Versus Sorafenib Plus Transarterial Chemoembolization in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase 3 Trial (Shata-001 Study)

Number of pages: 34 Posted: 06 Apr 2025
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 58 (980,173)

Abstract:

Loading...

Hepatocellular carcinoma, sorafenib, transcatheter arterial chemoembolization, hepatic arterial infusion chemotherapy, biomolecular exploratory, phosphofructokinase

6.

Efficacy of Radiofrequency Ablation Following Transarterial Chemoembolization Combined with Sorafenib for Intermediate Stage Recurrent Hepatocellular Carcinoma

Number of pages: 29 Posted: 16 Aug 2022
Sun Yat-sen University (SYSU) - Department of Liver Surgery, Hunan Normal University - Department of Hepatobiliary Surgery, Government of the People's Republic of China - Department of Interventional Ultrasound, Guangzhou Medical University - Laboratory of Interventional Radiology, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Medical Ultrasonics, Sun Yat-sen University (SYSU) - Center of Hepatic-Pancreatic-Biliary Surgery, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Hunan Normal University - Department of Hepatobiliary Surgery and Shanxi Provincial People's Hospital - Department of Ultrasound
Downloads 49 (1,074,648)

Abstract:

Loading...

Recurrent Hepatocellular Carcinoma, Intermediate-Stage, Transarterial Chemoembolization, Sorafenib, Radiofrequency Ablation